Nautilus Biotechnology In... (NAUT)
NASDAQ: NAUT
· Real-Time Price · USD
0.76
0.02 (2.43%)
At close: Jun 06, 2025, 3:59 PM
0.77
1.05%
After-hours: Jun 06, 2025, 04:02 PM EDT
2.43% (1D)
Bid | 0.73 |
Market Cap | 96M |
Revenue (ttm) | n/a |
Net Income (ttm) | -68.66M |
EPS (ttm) | -0.54 |
PE Ratio (ttm) | -1.41 |
Forward PE | -1.14 |
Analyst | Hold |
Ask | 0.98 |
Volume | 218,423 |
Avg. Volume (20D) | 173,898 |
Open | 0.75 |
Previous Close | 0.74 |
Day's Range | 0.74 - 0.78 |
52-Week Range | 0.66 - 3.09 |
Beta | 1.25 |
About NAUT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAUT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAUT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-18.18%
Nautilus Biotechnology shares are trading lower. T...
Unlock content with
Pro Subscription
11 months ago
+2.7%
Nautilus Biotechnology shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and a $6 price target.

1 month ago · seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call TranscriptNautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Execut...